Christopher J Langmead

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Topics

Cognitive Decline

Peripheral Blood

Alcohol Use Disorder

Top Venues

ACS chemical neuroscience

British journal of pharmacology

ACS pharmacology & translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Sabrina N Rahman, Daniel A McNaught-Flores, Yara Huppelschoten, Daniel da Costa Pereira, Arthur Christopoulos, Rob Leurs, Christopher J Langmead
Structural and Molecular Determinants for Isoform Bias at Human Histamine H 3 Receptor Isoforms. ACS chemical neuroscience 14 (4) (2023)
Leigh C Walker, Kade L Huckstep, Howard C Becker, Christopher J Langmead, Andrew J Lawrence
Targeting muscarinic receptors for the treatment of alcohol use disorders: opportunities and hurdles for clinical development. British journal of pharmacology (2023)
Yao Lu, Cassandra J Hatzipantelis, Christopher J Langmead, Gregory D Stewart
Molecular insights into orphan G protein-coupled receptors relevant to schizophrenia. British journal of pharmacology (2023)
Sabrina N Rahman, Daniel A McNaught-Flores, Yara Huppelschoten, Daniel da Costa Pereira, Arthur Christopoulos, Rob Leurs, Christopher J Langmead
Structural and Molecular Determinants for Isoform Bias at Human Histamine H 3 Receptor Isoforms. ACS chemical neuroscience (2023)
Maleesha Ubhayarathna, Christopher J Langmead, Natalie A Diepenhorst, Gregory D Stewart
Molecular and structural insights into the 5-HT 2C receptor as a therapeutic target for substance use disorders. British journal of pharmacology (2023)
Sabrina N Rahman, Daniel A McNaught-Flores, Yara Huppelschoten, Daniel da Costa Pereira, Arthur Christopoulos, Rob Leurs, Christopher J Langmead
Structural and Molecular Determinants for Isoform Bias at Human Histamine H 3 Receptor Isoforms. ACS chemical neuroscience 14 (4) (2023)
Sabrina N Rahman, Daniel A McNaught-Flores, Yara Huppelschoten, Daniel da Costa Pereira, Arthur Christopoulos, Rob Leurs, Christopher J Langmead
Structural and Molecular Determinants for Isoform Bias at Human Histamine H 3 Receptor Isoforms. ACS chemical neuroscience 14 (4) (2023)
Pramod C Nair, Justin M Chalker, Ross A McKinnon, Christopher J Langmead, Karen J Gregory, Tarun Bastiampillai
Trace Amine-Associated Receptor 1 (TAAR1): Molecular and Clinical Insights for the Treatment of Schizophrenia and Related Comorbidities. ACS pharmacology & translational science 5 (3) (2022)
Huong T M Nguyen, Emma T van der Westhuizen, Christopher J Langmead, Andrew B Tobin, Patrick M Sexton, Arthur Christopoulos, Celine Valant
Opportunities and challenges for the development of M 1 muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits. British journal of pharmacology (2022)
Wessel A C Burger, Patrick R Gentry, Alice E Berizzi, Ziva Vuckovic, Emma T van der Westhuizen, Geoff Thompson, Mahmuda Yeasmin, Dennis C Liotta, Patrick M Sexton, Christopher J Langmead, Andrew B Tobin, Arthur Christopoulos, Celine Valant, David M Thal
Identification of a Novel Allosteric Site at the M5 Muscarinic Acetylcholine Receptor. ACS chemical neuroscience 12 (16) (2021)
Leigh C Walker, Kate L Huckstep, Nicola A Chen, Lexi J Hand, Craig W Lindsley, Christopher J Langmead, Andrew J Lawrence
Muscarinic M4 and M5 receptors in the ventral subiculum differentially modulate alcohol seeking versus consumption in male alcohol-preferring rats. British journal of pharmacology 178 (18) (2021)
Cassandra J Hatzipantelis, Yao Lu, Daisy L Spark, Christopher J Langmead, Gregory D Stewart
β-Arrestin-2-Dependent Mechanism of GPR52 Signaling in Frontal Cortical Neurons. ACS chemical neuroscience 11 (14) (2020)
Daisy L Spark, Miaomiao Mao, Sherie Ma, Mohsin Sarwar, Cameron J Nowell, David M Shackleford, Patrick M Sexton, Jess Nithianantharajah, Gregory D Stewart, Christopher J Langmead
In the Loop: Extrastriatal Regulation of Spiny Projection Neurons by GPR52. ACS chemical neuroscience 11 (14) (2020)
Tracy M Josephs, Andrew N Keller, Elham Khajehali, Aaron DeBono, Christopher J Langmead, Arthur D Conigrave, Ben Capuano, Irina Kufareva, Karen J Gregory, Katie Leach
Negative allosteric modulators of the human calcium-sensing receptor bind to overlapping and distinct sites within the 7-transmembrane domain. British journal of pharmacology 177 (8) (2020)
Aaron M Bender, Hyekyung P Cho, Kellie D Nance, Kaelyn S Lingenfelter, Vincent B Luscombe, Patrick R Gentry, Karl Voigtritter, Alice E Berizzi, Patrick M Sexton, Christopher J Langmead, Arthur Christopoulos, Charles W Locuson, Thomas M Bridges, Sichen Chang, Jordan C O'Neill, Xiaoyan Zhan, Colleen M Niswender, Carrie K Jones, P Jeffrey Conn, Dennis C Liotta
Discovery and Optimization of Potent and CNS Penetrant M5-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold. ACS chemical neuroscience 9 (7) (2018)
Natalie A Diepenhorst, Katie Leach, Andrew N Keller, Patricia Rueda, Anna E Cook, Tracie L Pierce, Cameron Nowell, Philippe Pastoureau, Massimo Sabatini, Roger J Summers, William N Charman, Patrick M Sexton, Arthur Christopoulos, Christopher J Langmead
Divergent effects of strontium and calcium-sensing receptor positive allosteric modulators (calcimimetics) on human osteoclast activity. British journal of pharmacology 175 (21) (2018)
Darren M Riddy, Emily Goy, Philippe Delerive, Roger J Summers, Patrick M Sexton, Christopher J Langmead
Comparative genotypic and phenotypic analysis of human peripheral blood monocytes and surrogate monocyte-like cell lines commonly used in metabolic disease research. PloS one 13 (5) (2018)